Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence of Prototype Mini Nicotine Lozenge vs Nicorette Minis in Healthy Smokers
NCT03541044Phase 1Completed
- Sponsor
- GSK
- Start
- Jun 2018
- Primary completion
- Mar 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of nicotine in Tobacco Use Disorder (TUD) (2 arms), sponsored by GSK. Primary endpoints: Area Under the Plasma Concentration Versus Time Curve From Time Zero to Time t, Area Under the Plasma Concentration Versus Time Curve From Time Zero to Infinity and 1 more. Started Jun 2018; status: completed.
02
Drugs
nicotine
03
Conditions
Tobacco Use Disorder (TUD)
Beyond the preview
Go deeper on NCT03541044.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03541044.